{"transactions":[{"id":4634177,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-03T00:20:33.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to such option vest and become exercisable on September 30, 2027, and the remaining seventy-five percent (75%) of the shares subject to the option vest and become exercisable in substantially equal installments thereafter on each monthly anniversary of September 30, 2027 (or if there is no corresponding day in any such month, on the last day of each month) over three (3) years, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":575000,"derivative":{"exercise_price":1.05,"expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001746473-26-000117","document":"wk-form4_1790972430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000174647326000117/wk-form4_1790972430.xml","form_type":"4"}},{"id":798993,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-28T23:49:27.000Z","date":"2026-04-27","kind":"exercise","planned":true,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":41913,"derivative":{"exercise_price":3.7898,"expiration_date":"2023-08-08","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001628280-26-028054","document":"wk-form4_1777420165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026028054/wk-form4_1777420165.xml","form_type":"4"}},{"id":798992,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-28T23:49:27.000Z","date":"2026-04-27","kind":"sale","planned":true,"acquired":false,"shares":5500,"price":22.8782,"value":125830.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.51 to $23.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":55286,"source":{"system":"sec-edgar","filing":"0001628280-26-028054","document":"wk-form4_1777420165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026028054/wk-form4_1777420165.xml","form_type":"4"}},{"id":798991,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-28T23:49:27.000Z","date":"2026-04-27","kind":"exercise","planned":true,"acquired":true,"shares":5500,"price":3.7898,"value":20843.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":60786,"source":{"system":"sec-edgar","filing":"0001628280-26-028054","document":"wk-form4_1777420165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026028054/wk-form4_1777420165.xml","form_type":"4"}},{"id":827505,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-26T23:21:14.000Z","date":"2026-03-25","kind":"exercise","planned":true,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":47413,"derivative":{"exercise_price":3.7898,"expiration_date":"2023-08-08","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001628280-26-021543","document":"wk-form4_1774567271.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026021543/wk-form4_1774567271.xml","form_type":"4"}},{"id":827504,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-26T23:21:14.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":5500,"price":18.9508,"value":104229.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.55 to $19.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":55286,"source":{"system":"sec-edgar","filing":"0001628280-26-021543","document":"wk-form4_1774567271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026021543/wk-form4_1774567271.xml","form_type":"4"}},{"id":827503,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-26T23:21:14.000Z","date":"2026-03-25","kind":"exercise","planned":true,"acquired":true,"shares":5500,"price":3.7898,"value":20843.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":60786,"source":{"system":"sec-edgar","filing":"0001628280-26-021543","document":"wk-form4_1774567271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026021543/wk-form4_1774567271.xml","form_type":"4"}},{"id":858997,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T00:06:35.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":52913,"derivative":{"exercise_price":3.7898,"expiration_date":"2023-08-08","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001628280-26-015419","document":"wk-form4_1772755592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026015419/wk-form4_1772755592.xml","form_type":"4"}},{"id":858996,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T00:06:35.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":69213,"derivative":{"exercise_price":3.7898,"expiration_date":"2023-08-08","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001628280-26-015419","document":"wk-form4_1772755592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026015419/wk-form4_1772755592.xml","form_type":"4"}},{"id":858995,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-06T00:06:35.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":16300,"price":18.5227,"value":301920.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.45 to $18.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":55286,"source":{"system":"sec-edgar","filing":"0001628280-26-015419","document":"wk-form4_1772755592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026015419/wk-form4_1772755592.xml","form_type":"4"}},{"id":858994,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-06T00:06:35.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":true,"shares":16300,"price":3.7898,"value":61773.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":71586,"source":{"system":"sec-edgar","filing":"0001628280-26-015419","document":"wk-form4_1772755592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026015419/wk-form4_1772755592.xml","form_type":"4"}},{"id":858993,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-06T00:06:35.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":200,"price":18.45,"value":3690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":55286,"source":{"system":"sec-edgar","filing":"0001628280-26-015419","document":"wk-form4_1772755592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026015419/wk-form4_1772755592.xml","form_type":"4"}},{"id":858992,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-06T00:06:35.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":true,"shares":200,"price":3.7898,"value":757.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":55486,"source":{"system":"sec-edgar","filing":"0001628280-26-015419","document":"wk-form4_1772755592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026015419/wk-form4_1772755592.xml","form_type":"4"}},{"id":919721,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:36:11.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in sixteen equal quarterly installments following February 2, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":16.76,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001628280-26-005479","document":"wk-form4_1770240967.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828026005479/wk-form4_1770240967.xml","form_type":"4"}},{"id":958454,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-29T22:10:18.000Z","date":"2025-12-26","kind":"exercise","planned":false,"acquired":false,"shares":19789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option vested on July 24, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":98987,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":19789},"source":{"system":"sec-edgar","filing":"0001628280-25-059035","document":"wk-form4_1767046215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828025059035/wk-form4_1767046215.xml","form_type":"4"}},{"id":958453,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-29T22:10:18.000Z","date":"2025-12-26","kind":"exercise","planned":false,"acquired":true,"shares":19789,"price":3.7898,"value":74996.3522,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an ISO exercise and hold to acquire and retain direct share ownership of the issuer."}],"balance_after":55286,"source":{"system":"sec-edgar","filing":"0001628280-25-059035","document":"wk-form4_1767046215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000162828025059035/wk-form4_1767046215.xml","form_type":"4"}},{"id":988928,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-25T23:39:48.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":69413,"derivative":{"exercise_price":3.7898,"expiration_date":"2023-08-08","underlying":"Common Stock","underlying_shares":906},"source":{"system":"sec-edgar","filing":"0002034679-25-000006","document":"wk-form4_1764113985.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000006/wk-form4_1764113985.xml","form_type":"4"}},{"id":988927,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-25T23:39:48.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":4594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying this option vested on July 24, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":118776,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":4594},"source":{"system":"sec-edgar","filing":"0002034679-25-000006","document":"wk-form4_1764113985.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000006/wk-form4_1764113985.xml","form_type":"4"}},{"id":988926,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-25T23:39:48.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying this option vested on July 24, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":123370,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0002034679-25-000006","document":"wk-form4_1764113985.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000006/wk-form4_1764113985.xml","form_type":"4"}},{"id":988925,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-25T23:39:48.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":906,"price":18.8424,"value":17071.2144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.68 to $19.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":35497,"source":{"system":"sec-edgar","filing":"0002034679-25-000006","document":"wk-form4_1764113985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000006/wk-form4_1764113985.xml","form_type":"4"}},{"id":988924,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-25T23:39:48.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":906,"price":3.7898,"value":3433.5588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":36403,"source":{"system":"sec-edgar","filing":"0002034679-25-000006","document":"wk-form4_1764113985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000006/wk-form4_1764113985.xml","form_type":"4"}},{"id":988923,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-25T23:39:48.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":4594,"price":18.8424,"value":86561.9856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.68 to $19.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":35497,"source":{"system":"sec-edgar","filing":"0002034679-25-000006","document":"wk-form4_1764113985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000006/wk-form4_1764113985.xml","form_type":"4"}},{"id":988922,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-25T23:39:48.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":4594,"price":3.7898,"value":17410.3412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":40091,"source":{"system":"sec-edgar","filing":"0002034679-25-000006","document":"wk-form4_1764113985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000006/wk-form4_1764113985.xml","form_type":"4"}},{"id":988921,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-25T23:39:48.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":5500,"price":18.45,"value":101475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":35497,"source":{"system":"sec-edgar","filing":"0002034679-25-000006","document":"wk-form4_1764113985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000006/wk-form4_1764113985.xml","form_type":"4"}},{"id":988920,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-25T23:39:48.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":true,"shares":5500,"price":3.7898,"value":20843.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":40997,"source":{"system":"sec-edgar","filing":"0002034679-25-000006","document":"wk-form4_1764113985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000006/wk-form4_1764113985.xml","form_type":"4"}},{"id":1020375,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-10T21:23:20.000Z","date":"2025-10-09","kind":"exercise","planned":true,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option vested on July 24, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":128870,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0002034679-25-000003","document":"wk-form4_1760131397.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000003/wk-form4_1760131397.xml","form_type":"4"}},{"id":1020374,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-10-10T21:23:20.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":18.45,"value":405900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":35497,"source":{"system":"sec-edgar","filing":"0002034679-25-000003","document":"wk-form4_1760131397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000003/wk-form4_1760131397.xml","form_type":"4"}},{"id":1020373,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":51041,"kind":"person","name":"Raben David","position":1,"cik":"0002034679","reported_name":"Raben David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-10-10T21:23:20.000Z","date":"2025-10-09","kind":"exercise","planned":true,"acquired":true,"shares":22000,"price":3.7898,"value":83375.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":57497,"source":{"system":"sec-edgar","filing":"0002034679-25-000003","document":"wk-form4_1760131397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034679/000203467925000003/wk-form4_1760131397.xml","form_type":"4"}}]}